Gadolinium Deposition Disease Lawsuits
Patients who suffer from Nephrogenic systemic fibrosis or Gadolinium deposition disease may have grounds for a lawsuit against the manufacturers of these drugs. The toxic metal is not removed from the body right away. Instead, it stays in the body for years. In this article, we’ll explain the symptoms and the legal process surrounding this illness. If you or someone you love is suffering from the effects of Gadolinium, read on to learn more.
Gadolinium-based contrast agents
In recent years, lawsuits involving gadolinium-based contrast agents have emerged throughout the U.S. During one lawsuit, Chuck Norris and his wife Gena alleged that they developed Gadolinium deposition disease (GDD) after being given MRI tests. The couple, who were previously healthy, spent over $2 million on treatments to cure Gena of her illness. Gadolinium lingers in her body for years.
The symptoms of Gadolinium-based contrast agents are similar to those of the rare ailment, Nephrogenic Systemic Fibrosis, NSF. The latter causes the excessive formation of connective tissues, which results in hardening of the skin and other complications. It can be deadly, affecting the joints and skin. People who suffer from Gadolinium deposition disease may also experience pain or swelling of the gastrointestinal tract and other body parts.
The lawsuits allege that drug companies knew about the risks associated with gadolinium-based contrast agents but failed to warn doctors and patients about the risks. This negligence has led to millions of dollars in settlements for patients with chronic nephrogenic systemic fibrosis. Nonetheless, many lawsuits are still in their early stages. The next phase will be to file individual cases against gadolinium-based contrast agents.
Nephrogenic systemic fibrosis
There are now several lawsuits related to gadolinium exposure. Jeffrey Steiner, a man who developed the degenerative disease after getting gadolinium injections, filed one in federal court in June 2018. He claimed that the substance remained deposited in his kidneys and neuronal cells of his brain and that he was unable to work or perform daily activities. Judge Edward J. Davila dismissed the lawsuit due to jurisdictional issues.
Although there is no specific medical guidance for Gadolinium Deposition Disease, patients have reported symptoms. Many have experienced persistent headaches, kidney impairment, and even brain fog. Some even suffer from memory loss and confusion. Depending on the type of Gadolinium MRI you underwent, you may be eligible to file a lawsuit. In addition to medical bills, a lawsuit may also be beneficial if you lost your job because of the disease.
Symptoms
The symptoms of gadolinium deposition disease are often misunderstood, but there are warning signs to look out for. Gadolinium can remain in the body for months or even years after injection. Some people who are affected may even suffer cognitive and nervous system problems. Because of these problems, doctors have coined the term gadolinium deposition disease. In some cases, the manufacturers of gadolinium contrast dyes are liable for the injury.
The first symptom of gadolinium deposition disease is persistent symptoms, which usually occur hours or days after the contrast-enhanced MRI. In severe cases, the symptoms can persist for up to two months. The most vulnerable groups are children and pregnant women, as well as those who have had four or more contrast-enhanced MRIs. Patients with kidney disease are at high risk for gadolinium deposition disease, but other patients may also be susceptible.
Symptoms of Gadolinium deposition disease
MRI patients are at increased risk of developing a rare condition known as Symptoms of Gadolinium Deposition Disease (GDPD). This complication of medical imaging is caused by the use of gadolinium contrast dyes, which are a type of heavy metal. Although gadolinium is supposed to be eliminated from the body via the kidneys, exposure to the substance can cause its deposits to remain in the body for months or even years. People who develop Gadolinium Deposition Disease often experience bone pain, brain fog, and burning in tissues. These symptoms can appear within hours or take weeks to develop.
The remaining gadolinium in the body can become unbound from protective agents and cause a condition called nephrogenic systemic fibrosis. This disorder affects the skin and internal organs and can be fatal. Patients with impaired kidney function are at a higher risk of developing this disease. Those with kidney damage may also experience symptoms similar to those of NSFD. Therefore, a lawsuit can be filed on behalf of a patient who has suffered these problems.
Patients who suffer from Nephrogenic systemic fibrosis or Gadolinium deposition disease may have grounds for a lawsuit against the manufacturers of these drugs. The toxic metal is not removed from the body right away. Instead, it stays in the body for years. In this article, we’ll explain the symptoms and the legal process surrounding this…